Home

Gore has announced that the US Food and Drug Administration (FDA) has granted regulatory approval for commercial distribution for the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System, a unique thoracic endovascular aortic repair (TEVAR) solution combining new levels of control with the proven legacy and trusted performance of the Conformable GORE TAG Device. The device and delivery system provide new precision and predictable patient outcomes in the endovascular repair of aneurysms, transections, and Type B dissections of the descending thoracic aorta. A smaller-diameter primary delivery sleeve gives the device and system a lower profile across 10 device sizes.

The GORE ACTIVE CONTROL System provides controlled, two-stage deployment, with primary deployment to an intermediate diameter and a secondary deployment to full diameter. This design allows for continuous blood flow throughout the deployment with multiple opportunities to visualise and refine graft placement. It is also designed to allow for angulation of the proximal end of the device for improved seal and apposition. It gives physicians added precision in placement and angulation so they can take full advantage of the exceptional conformability of the Gore device and confidently provide a minimally-invasive solution to more patients.

No change was made to the stent graft itself, which, as the world’s most-studied TEVAR device, has demonstrated long-term freedom from device-related reintervention (93.1%) and low complication rates (zero migrations, fractures, or compressions). Large device oversizing windows were engineered, tested, and proven to accommodate differences in proximal and distal landing zone diameters; a unique 6% to 33% oversizing window allows physicians to choose the optimal radial force to fit patient anatomy and aetiology, whether treating a young trauma patient or a fragile dissected aorta. The 16mm to 42mm range can be treated with as few as five sizes, allowing providers to stock fewer devices while treating a broader range of patients.

“The GORE TAG Device family has a legacy of trusted performance and durability, and we knew we could build on that by enhancing control during deployment, which would help make TEVAR procedures more predictable for physicians,” says Eric Zacharias, a vascular business leader at Gore. “Physicians can now deploy our thoracic stent graft in the descending thoracic aorta with more operative ease, even in those patients with challenging angulated aortic arches, and meet the clinical and practical challenges of TEVAR with confidence. With this latest product iteration, Gore is continuing its unparalleled commitment to developing solutions that advance endovascular solutions for diseases of the aorta.”

Source CardiovascularNews

Duc Tin clinic

Chia sẽ qua facebook bài: Gore receives FDA approval for the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL

Chia sẽ qua google bài: Gore receives FDA approval for the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL

Chia sẽ qua twitter bài: Gore receives FDA approval for the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL

Chia sẽ qua MySpace bài: Gore receives FDA approval for the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL

Chia sẽ qua LinkedIn bài: Gore receives FDA approval for the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL

Chia sẽ qua stumbleupon bài: Gore receives FDA approval for the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL

Chia sẽ qua icio bài: Gore receives FDA approval for the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL

Chia sẽ qua digg bài: Gore receives FDA approval for the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL

Chia sẽ qua yahoo bài: Gore receives FDA approval for the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL

Tin tức liên quan

Vesteck completes first-in-human use of several Suture-Tight devices

Age is just a number: Individual patient data meta-analysis probes safety of CEA in the elderly

Artificial intelligence can predict risk of complications after endovascular aneurysm repair

Bluegrass Vascular announces Journal of Vascular Surgery paper reporting use of Surfacer system

Vascular access creation: EndoAVF keeps future options open, but is not a replacement for surgical fistulas

SUPPORT CONSULTANT

Make an Appointment

I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

I sincerely thank you !. Tel: 0938303275

Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.